Allergan
Case Analysis
Allemande Left, then Do-Si-Do,
Find a Partner
(2004)
Team 2
THE CURRENT SITUATION
A. Current Performance
Allergan is one of the smaller pharmaceutical companies in the industry, it's product lines include ophthalmology, neuromodulator, and dermatology. Allergan has experienced recorded sales growth; 16% over the previous year. As Allergan entered 2004, it has a strong pipeline of projects, with most of its resources focusing on ophthalmology and neuromodulator businesses. The company has indicated a desire to expand its smallest platform (i.e., dermatology) via external resources.
B. Strategic Posture
1. Mission:
Improving Lives: For more than half a century, Allergan's mission has remained constant: to deliver high quality products to our customers, and satisfy unmet medical needs, and improve patients' lives.
? To develop a unique level of understanding of our customers in order to implement operational strategies that provides the greatest value for our customers and stakeholders.
? To become the partner of choice for ever better health care through the value of our technological innovation, industry leadership, partnering skills and relationships, worldwide infrastructure, research, and manufacturing capabilities.
? To continue as an innovative, technology driven, global health care company focused on specialty pharmaceuticals and eye care products that deliver value to customers, satisfy unmet medical needs, and improve patients' lives.
2. Objectives: (Allergan 10-K, 2004)
? Profitability. Achieving a sufficient level of profits that allows us to finance our growth and fulfill corporate objectives through self-generated resources ...